Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03187951 · ClinicalTrials.gov registry record · NA
PancFit: Multimodal Exercise During Preoperative Therapy for Pancreatic Cancer
A NA study of Pancreatic Cancer and Other Disorders of Glucose Regulation and Pancreatic Internal Secretion, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 152
- Enrollment target
- 1
- Study location
NCT03187951: Active NA study of Pancreatic Cancer and Other Disorders of Glucose Regulation and Pancreatic Internal Secretion, sponsored by M.D. Anderson Cancer Center.
NCT03187951 is a NA study of Pancreatic Cancer and Other Disorders of Glucose Regulation and Pancreatic Internal Secretion that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 152 participants, below the 393-participant average among 278 other Pancreatic Cancer trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03187951, a NA study of Pancreatic Cancer and Other Disorders of Glucose Regulation and Pancreatic Internal Secretion, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 152 participants
- Enrollment target
- 1
- Study location
Study Summary
Any time the words "you," "your," "I," or "me" appear, it is meant to apply to the potential participant. The goal of this clinical research study is to learn if regular exercise and behavioral skills training can help to improve physical activity in patients with pancreatic cancer who are scheduled to receive chemotherapy and/or radiation before standard-of-care surgery. This is an investigational study. Up to 128 participants will be enrolled on this study. All will take part at MD Anderson.
Primary Outcome
Primary endpoint is the change in 6MWT distance, measured in meters, between the time at which preoperative therapy is administered (T0) and the time at which it ends (T1).
Conditions Studied
Interventions
- BEHAVIORAL Questionnaires
- BEHAVIORAL Nutritional Questionnaire and Nutritional Counseling
- OTHER Booklet
- BEHAVIORAL Aerobic Exercise and Strength Training Exercises
- BEHAVIORAL Phone Calls
Study Locations (1)
Texas
- University of Texas MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 152 participants |
| Start Date | 2017-06-13 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What the registry record for NCT03187951 still lists
NCT03187951 is an interventional study that assigns participants to a tested intervention. The registered 152 participants enrollment target is mid-sized for trials with a published cap, below the 393-participant average among 278 other Pancreatic Cancer trials with a reported enrollment target (61% lower).
The record links to 2 conditions, with Pancreatic Cancer appearing as the primary indexed condition, and to 5 interventions - of which Questionnaires is the first listed.
NCT03187951 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT03187951 about?
NCT03187951 is a clinical study titled "PancFit: Multimodal Exercise During Preoperative Therapy for Pancreatic Cancer". Any time the words "you," "your," "I," or "me" appear, it is meant to apply to the potential participant. The goal of this clinical research study is to learn if regular exercise and behavioral skills training can help to improve physical activity in patients with pancreatic cancer who are schedule...
What is the current status of trial NCT03187951?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 152 participants. The study started on 2017-06-13. Estimated completion is 2026-12-31.
What conditions does trial NCT03187951 study?
This clinical trial studies the following conditions: Pancreatic Cancer, Other Disorders of Glucose Regulation and Pancreatic Internal Secretion.
What interventions are being tested in trial NCT03187951?
The interventions under investigation include: Questionnaires (BEHAVIORAL), Nutritional Questionnaire and Nutritional Counseling (BEHAVIORAL), Booklet (OTHER), Aerobic Exercise and Strength Training Exercises (BEHAVIORAL), Phone Calls (BEHAVIORAL).
Who is sponsoring clinical trial NCT03187951?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03187951 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pancreatic Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03187951's enrollment target sits among peer trials
152 78th of 278 higher than 201 of 278 other Pancreatic Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pancreatic Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer
RECRUITING · NA
-
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
RECRUITING · NA
-
EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope
RECRUITING · NA
-
Computed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary Cancer
RECRUITING · NA
-
Support Through Remote Observation and Nutrition Guidance Program (STRONG-PCS)
RECRUITING · NA
-
GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03328078 · 152 participants · Phase 1
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- NCT04458532 · 152 participants · NA
Exercise Therapy to Improve Cardiovascular Health in Post-Menopausal Women After Treatment for Early Stage Breast Cancer
- NCT04858334 · 152 participants · Phase 2
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
- NCT04993859 · 152 participants
Impact of Chemotherapy on Urinary Biomarkers and Non-Invasive Urodynamics in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI